Objective To observe the dynamic change on social function in children with attention deficit hyperactivity disorder(ADHD) after treatment with methylphenidate-release tablets and compare the difference on social function between the children with ADHD and the normal children. Methods Totally 34 children with ADHD and 35 normal children were included.ADHD children were treated with methylphenidate-release tablets for 24 weeks,social function were assessed with Weiss's function defect level rating scale respectively at baseline,the end of 8th week and the end of 24th week. Results 1) The scores of family,learning and school,life skills,self-management,social activities,adventure activities and the total score of Weiss's function defect level rating scale had decreased gradually after prolonged treatment (P<0.001).2)After 24 weeks treatment,there were no differences on life skills and adventure activities between the children with ADHD and the normal children,there were significant difference on family,learning and school,self-management,social activities. Conclusion The social function of ADHD can effectively improved after taking methylphenidate-release tablets,and the downtrend is gradually decreased along with the prolonged treatment.
Key words
attention deficit hyperactivity disorder /
methylphenidate-release tablets /
social function /
child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Shiels K,Hawk LW.Self-regulation in ADHD:The role of error processing[J].Clin Psychol Rev,2010,30(8):951-961.
[2] Coghill D.The impact of medications on quality of life in Attention-Deficit Hyperactivity Disorder[J].CNS Drug,2010,24(10):843-866.
[3] American Psychiatric Association.Diagnostic and statistical manual of mental disorders (4th ed.text rev.)[M].Washington,DC:American Psychiatric Association:2000.
[4] 钱英,曲珊,杜巧新,等.Weiss 功能缺陷程度量表父母版的信效度[J].中国心理卫生杂志,2011,25(10):767-771.
[5] Santos K,Palmini A,Radziuk AL,et al.The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies[J].Developmental Medicine & Child Neurology,2013,55(7):654-660.
[6] Deborah A,Cynthia W,Michael G,et al.Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms[J].Journal Of Child And Adolescent Psychopharmcology,2013,23(5):337-351.
[7] Surman CB,Hammerness PG,Pion K,et al.Do stimulants improve functioning in adults with ADHD? A review of the literature[J].Eur Neuropsychopharmacol,2013,23(6):528-533.
[8] Hammerness P,Fried R,Petty C,et al.Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD[J].Child Neuropsychology,2014,20(3):319-327.
[9] Meftagh SD,Najimi A,Mohammadi N,et al.The most effective intervention for attention deficit hyperactivity disorder:Using continuous performance test[J].Psychiatria Danubina,2014,26(2):165-171.
[10] Hwang JW,Kim B,Kim Y,et al.Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder[J].Hum.Psychopharmacol Clin Exp,2013,28(6):600-607.
[11] Coghill D.The impact of medications on quality of life in attention-deficit hyperactivity disorder[J].CNS Drug,2010,24(10):843-866.
PDF(430 KB)
